Development Level

Tchem 3 | 1,890
Tclin 3 | 602
Tbio 2 | 10,625

Collection

GPCR: IDG Consortium (Targets) 1 | 127

IMPC Phenotype

decreased CD8-positive, alpha-... 1 | 26
decreased T cell number 1 | 31
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased rib number 1 | 59
female infertility 1 | 34
increased mean corpuscular vol... 1 | 91

Disease

medulloblastoma, large-cell 5 | 6,234
Migraine 4 | 79
Parkinson's disease 4 | 364
Schizophrenia 4 | 503
pilocytic astrocytoma 4 | 3,086
primitive neuroectodermal tumor 4 | 3,031
Hyperactive behavior 3 | 31
Hypotension 3 | 53
Vascular disease 3 | 281
atypical teratoid / rhabdoid tumor 3 | 4,369
glioblastoma 3 | 5,572
lung carcinoma 3 | 2,844
oligodendroglioma 3 | 2,849
psoriasis 3 | 6,685
Acromegaly 2 | 40
Alcohol dependence 2 | 107
Amphetamine-Related Disorders 2 | 74
Anxiety Disorders 2 | 37
Asthma 2 | 349
Atopic dermatitis 2 | 944
Attention deficit hyperactivity disorder 2 | 156
Autistic Disorder 2 | 320
Bipolar Disorder 2 | 266
Breast cancer 2 | 3,098
Cancer 2 | 2,346
Cardiomyopathies 2 | 90
Cocaine-Related Disorders 2 | 88
Huntington's disease 2 | 72
Hyperprolactinemia 2 | 22
Irritable bowel syndrome 2 | 59
Nicotine dependence 2 | 53
Pain 2 | 70
Panic disorder 2 | 55
Parkinson Disease 2 | 105
Seizures 2 | 95
adult high grade glioma 2 | 2,148
astrocytic glioma 2 | 2,241
colon cancer 2 | 1,475
ductal carcinoma in situ 2 | 1,745
ependymoma 2 | 2,514
gastric carcinoma 2 | 832
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
lung adenocarcinoma 2 | 2,714
medulloblastoma 2 | 1,524
non-small cell lung cancer 2 | 2,798
osteosarcoma 2 | 7,933
ovarian cancer 2 | 8,491
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
pediatric high grade glioma 2 | 2,712
pituitary cancer 2 | 1,972
post-traumatic stress disorder 2 | 45
posterior fossa group A ependymoma 2 | 1,511
Acute Lung Injury 1 | 18
Adverse reaction to drug 1 | 54
Amenorrhea 1 | 60
Anorexia 1 | 15
Apraxia 1 | 25
Asthma management 1 | 20
Bronchial Hyperreactivity 1 | 13
Bronchitis 1 | 44
Catalepsy 1 | 15
Cholera 1 | 33
Cluster headache syndrome 1 | 8
Common cold 1 | 63
Constipation 1 | 43
Depressive disorder 1 | 48
Diarrhea 1 | 155
Drug allergy 1 | 36
Dystonia 1 | 77
Ectropion 1 | 18
Edema 1 | 38
Entropion 1 | 12
Generalized anxiety disorder 1 | 29
Gilles de la Tourette syndrome 1 | 47
Heroin dependence 1 | 30
Hirschsprung's disease 1 | 44
Hypokalemia 1 | 40
Impotence 1 | 45
Lagophthalmos 1 | 8
Liver Cirrhosis, Experimental 1 | 108
Mammary Neoplasms 1 | 410
Myocardial Perfusion Imaging Adjunct 1 | 25
Nasal congestion 1 | 24
Nasal discharge 1 | 26
Neoplasm Metastasis 1 | 138
Paronychia 1 | 7
Paroxysmal supraventricular tachycardia 1 | 11
Postencephalitic parkinsonism 1 | 12
Psychoses, Substance-Induced 1 | 17
Psychotic Disorders 1 | 20
Pulmonary emphysema 1 | 34
Rhinitis 1 | 46
Sleep Initiation and Maintenance Disorders 1 | 3
Squamous cell carcinoma of esophagus 1 | 82
Substance Withdrawal Syndrome 1 | 55
Substance abuse 1 | 55
Sudden infant death syndrome 1 | 34
chronic kidney disease 1 | 90

Tissue

Cardiovascular System 8 | 17,957
Digestive Tract 8 | 18,472
Endocrine System 8 | 18,511
Female tissues 8 | 18,646
Liver and Pancreas 8 | 18,135
Male tissues 8 | 17,968
Nervous System 8 | 18,560
Respiratory system 8 | 17,483
Skin and soft tissues 8 | 18,114
Urinary Tract 8 | 18,443
Blood and immune system 7 | 17,994

Target Family

GPCR 6 | 408
Enzyme 1 | 4,146
Non-IDG 1 | 11,969

GO Process

positive regulation of adenyla... 8 | 8
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 367 | 367
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
chemical synaptic transmission 238 | 238
MAPK cascade 237 | 237
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 199 | 199
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 180 | 180
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 175 | 175
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
protein folding 162 | 162
negative regulation of canonic... 161 | 161
response to lipopolysaccharide 161 | 161
T cell receptor signaling path... 160 | 160
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
homophilic cell adhesion via p... 155 | 155
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
receptor-mediated endocytosis 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2-M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
type I interferon signaling pa... 130 | 130
endocytosis 129 | 129

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Adenosine receptor A2a ADORA2A Tclin GPCR -2.96884 923.3 273
Pituitary adenylate cyclase-activating polypeptide ADCYAP1 Tchem Enzyme -3.03655 1222.0 164
VIP peptides VIP Tbio Non-IDG -3.55139 4022.9 276
D(1B) dopamine receptor DRD5 Tchem GPCR -2.29410 171.5 274
Corticotropin-releasing factor receptor 1 CRHR1 Tclin GPCR -2.86819 704.2 314
D(1A) dopamine receptor DRD1 Tclin GPCR -2.52538 283.0 450
Adhesion G-protein coupled receptor D1 ADGRD1 Tbio GPCR -0.88058 8.25 111
G-protein coupled estrogen receptor 1 GPER1 Tchem GPCR -2.73735 639.4 267